We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Astellas Pharma Inc (PK) | USOTC:ALPMY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.01 | 0.10% | 9.55 | 9.47 | 9.59 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 9.59 | 9.53 | 9.54 | 452,047 | 21:06:02 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/12/2023 | 22:53 | DJN | Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev |
| 30/11/2023 | 23:04 | DJN | Astellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License.. |
| 22/9/2023 | 12:02 | DJN | Merck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits Endpoints |
| 07/8/2023 | 15:41 | DJN | Poseida Therapeutics Shares Leap on Astellas Investments |
| 07/8/2023 | 14:58 | DJN | Poseida Therapeutics in $50 Million Investment Deal With Astellas |
| 01/5/2023 | 01:57 | DJN | Astellas Pharma to Buy Iveric Bio for About $5.9 Billion |
1 Year Astellas Pharma (PK) Chart |
Intraday Astellas Pharma (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
